Sana EVP exercises 125K RSUs, 41K shares used
Sana Biotechnology, Inc. (SANA) reported insider equity transactions by EVP and Chief Scientific Officer Dhavalkumar Dhirajlal Patel.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Sana Biotechnology, Inc. (SANA) reported insider equity transactions by EVP and Chief Scientific Officer Dhavalkumar Dhirajlal Patel. On August 26, 2026, he exercised 125,000 Restricted Stock Units, receiving 125,000 shares of common stock, and his RSU position was reported as 250,000 units afterward. On August 27, 2026, 41,158 common shares were delivered or withheld at $4.11 per share for payment of exercise price or tax liability related to the equity award.
Insider Trade Summary
125,000 shares exercised/converted
Exercise
3 txns
Insider
PATEL DHAVALKUMAR DHIRAJLAL
Role
EVP, Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 41,158 | $4.11 | $169K |
| Exercise | Restricted Stock Units F1, F2 | 125,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 125,000 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 250,000 contracts (Direct);
Common Stock — 183,352 shares (Direct)
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of Sana Biotechology, Inc. ("Sana") common stock.
- F2. The award vested as to 25% of the restricted stock units on each of August 26, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of August 26, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
Key Figures
Restricted Stock Units exercised: 125,000 units
Common Stock acquired from RSUs: 125,000 shares
Shares delivered or withheld: 41,158 shares
+4 more
7 metrics
Restricted Stock Units exercised
125,000 units
RSUs exercised or converted on August 26, 2026
Common Stock acquired from RSUs
125,000 shares
Common shares received on exercise or conversion of RSUs on August 26, 2026
Shares delivered or withheld
41,158 shares
Common shares used for payment of exercise price or tax liability on August 27, 2026
Per-share value for F transaction
$4.11 per share
Price used to value shares delivered or withheld on August 27, 2026
RSUs remaining after transaction
250,000 units
Restricted Stock Units position reported after August 26, 2026 transaction
Vesting tranches already vested
25% on August 26, 2025; 25% on August 26, 2026
Two of four annual RSU vesting installments completed
Future vesting installments
2 equal installments
Remaining RSUs vest on August 26, 2027 and August 26, 2028, subject to continuous service
Key Terms
Restricted Stock Units, exercise price or tax liability, continuous service, derivative security
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise price or tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"
continuous service financial
"provided that the reporting person provides continuous service to Sana"
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions were reported at Sana Biotechnology (SANA)?
The EVP and Chief Scientific Officer, Dhavalkumar Dhirajlal Patel, exercised 125,000 Restricted Stock Units into 125,000 common shares on August 26, 2026, and on August 27, 2026, 41,158 common shares were delivered or withheld to pay the exercise price or tax liability.
How many Sana (SANA) RSUs did the EVP exercise and what did he receive?
On August 26, 2026, the EVP exercised 125,000 Restricted Stock Units, each representing a right to receive one share of Sana common stock, and received 125,000 common shares as a result of this exercise or conversion.
What RSU balance was reported after the Sana (SANA) insider transaction?
After the August 26, 2026 transaction, the reporting person’s Restricted Stock Unit position was listed as 250,000 RSUs, each representing a contingent right to receive one share of Sana common stock, subject to the stated vesting conditions.
What is the vesting schedule for the Sana (SANA) RSU award in this filing?
The award vested as to 25% of the RSUs on August 26, 2025 and 25% on August 26, 2026. The remaining RSUs will vest in two equal installments on August 26, 2027 and August 26, 2028, if continuous service to Sana is maintained.
Was the Sana (SANA) insider transaction under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote indicating that the transactions were made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
